1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4.
Global Influenza Diagnostics Market Outlook
4.1. Market Size &
Forecast
4.1.1. By Value
4.2. Market Share &
Forecast
4.2.1. By Test Type (Traditional Diagnostic Test, Molecular
Diagnostic Assay)
4.2.2. By End user (Hospital, Laboratories, Others)
4.2.3. By
Region
4.2.4. By Company (2023)
4.3. Market Map
4.3.1. By Test Type
4.3.2. By End-user
4.3.3. By Region
5.
Asia Pacific Influenza Diagnostics Market Outlook
5.1. Market Size &
Forecast
5.1.1. By Value
5.2. Market Share &
Forecast
5.2.1. By
Test Type
5.2.2.
By End user
5.2.3. By Country
5.3. Asia Pacific:
Country Analysis
5.3.1. China Influenza
Diagnostics Market Outlook
5.3.1.1.
Market Size & Forecast
5.3.1.1.1.
By Value
5.3.1.2.
Market Share & Forecast
5.3.1.2.1.
By Test Type
5.3.1.2.2.
By End user
5.3.2. India Influenza
Diagnostics Market Outlook
5.3.2.1.
Market Size & Forecast
5.3.2.1.1.
By Value
5.3.2.2.
Market Share & Forecast
5.3.2.2.1.
By Test Type
5.3.2.2.2.
By End user
5.3.3. Australia Influenza
Diagnostics Market Outlook
5.3.3.1.
Market Size & Forecast
5.3.3.1.1.
By Value
5.3.3.2.
Market Share & Forecast
5.3.3.2.1.
By Test Type
5.3.3.2.2.
By End user
5.3.4. Japan Influenza
Diagnostics Market Outlook
5.3.4.1.
Market Size & Forecast
5.3.4.1.1.
By Value
5.3.4.2.
Market Share & Forecast
5.3.4.2.1.
By Test Type
5.3.4.2.2.
By End user
5.3.5. South Korea Influenza
Diagnostics Market Outlook
5.3.5.1.
Market Size & Forecast
5.3.5.1.1.
By Value
5.3.5.2.
Market Share & Forecast
5.3.5.2.1.
By Test Type
5.3.5.2.2.
By End user
6.
Europe Influenza Diagnostics Market Outlook
6.1. Market Size &
Forecast
6.1.1. By Value
6.2. Market Share &
Forecast
6.2.1.
By Test Type
6.2.2. By
End user
6.2.3. By Country
6.3. Europe: Country
Analysis
6.3.1. France Influenza Diagnostics
Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Test Type
6.3.1.2.2.
By End user
6.3.2. Germany Influenza
Diagnostics Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Test Type
6.3.2.2.2.
By End user
6.3.3. Spain Influenza
Diagnostics Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Test Type
6.3.3.2.2.
By End user
6.3.4. Italy Influenza
Diagnostics Market Outlook
6.3.4.1.
Market Size & Forecast
6.3.4.1.1.
By Value
6.3.4.2.
Market Share & Forecast
6.3.4.2.1.
By Test Type
6.3.4.2.2.
By End user
6.3.5. United Kingdom Influenza
Diagnostics Market Outlook
6.3.5.1.
Market Size & Forecast
6.3.5.1.1.
By Value
6.3.5.2.
Market Share & Forecast
6.3.5.2.1.
By Test Type
6.3.5.2.2.
By End user
7.
North America Influenza Diagnostics Market Outlook
7.1. Market Size &
Forecast
7.1.1. By Value
7.2. Market Share &
Forecast
7.2.1.
By Test Type
7.2.2. By
End user
7.2.3. By Country
7.3. North America:
Country Analysis
7.3.1. United States Influenza
Diagnostics Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Test Type
7.3.1.2.2.
By End user
7.3.2. Mexico Influenza
Diagnostics Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Test Type
7.3.2.2.2.
By End user
7.3.3. Canada Influenza
Diagnostics Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Test Type
7.3.3.2.2.
By End user
8.
South America Influenza Diagnostics Market Outlook
8.1. Market Size &
Forecast
8.1.1. By Value
8.2. Market Share &
Forecast
8.2.1.
By Test Type
8.2.2. By
End user
8.2.3. By Country
8.3. South America:
Country Analysis
8.3.1. Brazil Influenza
Diagnostics Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Test Type
8.3.1.2.2.
By End user
8.3.2. Argentina Influenza
Diagnostics Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Test Type
8.3.2.2.2.
By End user
8.3.3. Colombia Influenza
Diagnostics Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Test Type
8.3.3.2.2.
By End user
9.
Middle East and Africa Influenza Diagnostics Market
Outlook
9.1. Market Size &
Forecast
9.1.1. By Value
9.2. Market Share &
Forecast
9.2.1.
By Test Type
9.2.2. By
End user
9.2.3. By Country
9.3. MEA: Country
Analysis
9.3.1. South Africa Influenza
Diagnostics Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Test Type
9.3.1.2.2.
By End user
9.3.2. Saudi Arabia Influenza
Diagnostics Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Test Type
9.3.2.2.2.
By End user
9.3.3. UAE Influenza
Diagnostics Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Test Type
9.3.3.2.2.
By End user
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends &
Developments
11.1. Recent Developments
11.2. Product Launches
11.3. Mergers &
Acquisitions
12. Global Influenza
Diagnostics Market: SWOT Analysis
13.
Porter’s Five Forces Analysis
13.1. Competition in the
Industry
13.2. Potential of New
Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute
Product
14. Company Profile
14.1. Abbott Laboratories Limited
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Product &
Services
14.1.5. Financials (In case
of listed)
14.1.6. Recent Developments
14.1. 7. SWOT Analysis
14.2. Becton, Dickinson
and Company
14.3. Coris BioConcept
14.4. DiaSorin SpA
14.5. F. Hoffmann-La Roche
Ltd
14.6. Meridian Bioscience
Inc
14.7. Quidel Corporation
14.8. Sekisui Diagnostics
14.9. Thermo Fisher
Scientific Inc
15. Strategic Recommendations
16. About Us & Disclaimer